Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Saved in:
| Title: | Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. |
|---|---|
| Authors: | Nunes EV; New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA., Bisaga A; New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA., Krupitsky E; St Petersburg Pavlov State Medical University, St Petersburg, Russia.; Department of Addictions, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, St Petersburg, Russia., Nangia N; Alkermes, Inc., Waltham, MA, USA., Silverman BL; Alkermes, Inc., Waltham, MA, USA., Akerman SC; Alkermes, Inc., Waltham, MA, USA., Sullivan MA; New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA.; Alkermes, Inc., Waltham, MA, USA. |
| Source: | Addiction (Abingdon, England) [Addiction] 2020 Feb; Vol. 115 (2), pp. 239-246. Date of Electronic Publication: 2019 Aug 04. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
